Year: 2022
Type: article
Abstract: BACKGROUND: There is considerable evidence that epigenetic mechanisms and DNA methylation are critical drivers of immune cell lineage differentiation and activation. However, there has been limited coordinated investigation of common epigenetic pathways among cell lineages. Further, it remains unclear if long-lived memory cell subtypes differentiate distinctly by cell lineages. RESULTS: We used the Illumina EPIC array to investigate the consistency of DNA methylation in B cell, CD4 T, and CD8 T naïve and memory cells states. In the process of naïve to memory activation across the three lineages, we identify considerable shared epigenetic regulation at the DNA level for immune memory generation. Further, in central to effector memory differentiation, our analyses revealed specific CpG dinucleotides and genes in CD4 T and CD8 T cells with DNA methylation changes. Finally, we identified unique DNA methylation patterns in terminally differentiated effector memory (TEMRA) CD8 T cells compared to other CD8 T memory cell subtypes. CONCLUSIONS: Our data suggest that epigenetic alterations are widespread and essential in generating human lymphocyte memory. Unique profiles are involved in methylation changes that accompany memory genesis in the three subtypes of lymphocytes.
Source: Clinical Epigenetics
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,190
Awards: EPIGENETIC MODIFICATIONS OF CYTOSINES IN CLEAR CELL KIDNEY CARCINOGENESIS AND SURVIVAL, G1304394381, G1740029671, Center for Molecular Epidemiology, G2122358390, G22827645, G3045512105, Epigenetic Modifications of Cytosines in Clear Cell Kidney Carcinogenesis and Survival, (PQ3) Immune epigenetic biomarkers of bladder cancer outcomes, G4119534169, G4717397149, Immune epigenetic biomarkers of survival in glioma epidemiology, G5914768259, G6271369194, G666595014, G6723538863, G700021213, G7448966117, G7988166024, DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy, The Kansas Institute for Precision Medicine, Brain Tumor SPORE Grant
OpenAlex ID: W4311731171
